2023
DOI: 10.1016/j.tips.2022.08.003
|View full text |Cite
|
Sign up to set email alerts
|

Odorant receptors as potential drug targets

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
11
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(11 citation statements)
references
References 15 publications
0
11
0
Order By: Relevance
“…3,4 The investigation of the physiological roles of these extranasal ORs, as well as their possible involvement in pathological conditions, is attracting a growing interest. 5,6 Moreover, given that GPCRs are the target of ~34% of FDA-approved drugs 7 and the wide range of biologically active molecules binding to ORs, 8 these receptors are being explored as potential novel drug targets. 9,10 However, the lack of high-resolution structures for ORs has hindered the understanding of their functional mechanisms and the development of OR-targeting drugs.…”
Section: Structure Predictionmentioning
confidence: 99%
See 1 more Smart Citation
“…3,4 The investigation of the physiological roles of these extranasal ORs, as well as their possible involvement in pathological conditions, is attracting a growing interest. 5,6 Moreover, given that GPCRs are the target of ~34% of FDA-approved drugs 7 and the wide range of biologically active molecules binding to ORs, 8 these receptors are being explored as potential novel drug targets. 9,10 However, the lack of high-resolution structures for ORs has hindered the understanding of their functional mechanisms and the development of OR-targeting drugs.…”
Section: Structure Predictionmentioning
confidence: 99%
“…3,4 The investigation of the physiological roles of these extranasal ORs, as well as their possible involvement in pathological conditions, is attracting a growing interest. 5,6 Moreover, given that GPCRs are the target of ∼34% of FDA-approved drugs 7 and the wide range of biologically active molecules binding to ORs, 8 these receptors are being explored as potential novel drug targets. 9,10 However, the lack of high-resolution structures for ORs has hindered the understanding of their functional mechanisms and the development of OR-targeting drugs.Recently, the field of computational biology has made significant strides in protein structure prediction, following the development of AlphaFold2, 11 a deep learning(DL)-based algorithm that can predict the 3D structures of proteins from their amino acid sequences with high accuracy.…”
mentioning
confidence: 99%
“…The human genome encodes for approximately 800 GPCRs, out of which 50% are ORs . Although initially identified in the nose, ORs are expressed in different parts of the body. , The investigation of the physiological roles of these extranasal ORs, as well as their possible involvement in pathological conditions, is attracting a growing interest. , Moreover, given that GPCRs are the target of ∼34% of FDA-approved drugs and the wide range of biologically active molecules binding to ORs, these receptors are being explored as potential novel drug targets. , However, the lack of high-resolution structures for ORs has hindered the understanding of their functional mechanisms and the development of OR-targeting drugs.…”
Section: Initial Modelsmentioning
confidence: 99%
“…Here, we take advantage of the genotype-tissue expression (GTEx) public data set ( Consortium, 2013 ) to investigate the tissue expression patterns of protein-coding olfactory receptor (OR) genes. OR genes account for approximately 50% of G protein-coupled receptor genes, which constitute the largest group in human membrane receptors ( Naressi et al, 2022 ). ORs are known to be distributed at many tissues, such as lung, heart, kidney, brain, prostate, airway, and testis ( Kang and Koo, 2012 ; Massberg and Hatt, 2018 ; Oh, 2018 ; Lee et al, 2019 ; Raka et al, 2021 ).…”
Section: Introductionmentioning
confidence: 99%